Bookimedは鼻茸治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。鼻茸治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。鼻茸治療の旅路でお一人になることはありません。
Dr. Nicola Vione has performed thousands of procedures in functional and facial plastic surgery. He is a specialist in otorhinolaryngology at Santa Caterina da Siena clinic in Turin. Dr. Vione serves as a Professor of Functional and Aesthetic Surgery of the Nose.
Italy offers advanced treatments for nasal polyps including monoclonal antibodies like Dupilumab and minimally invasive surgery. Patients access Functional Endoscopic Sinus Surgery (FESS) at Joint Commission International-accredited facilities. Medical management focuses on nasal corticosteroids and biologics. These therapies effectively reduce inflammation and prevent recurrence in severe cases.
Bookimed Expert Insight: Italian clinics like Ospedale San Carlo di Nancy balance massive patient volumes with high specialization. Dr. Nicola Vione at Santa Caterina da Siena uses preservation techniques to ensure faster recovery. Patients should look for centers linked to major research foundations for access to the latest biologics. For example, Mater Olbia Hospital combines expertise from Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
Patient Consensus: Patients note that choosing private care avoids the 6-12 month public health wait times. Many emphasize that daily saline rinses are essential to prevent the high risk of recurrence.
Italy offers advanced nasal polyp care through specialized ENT departments in Rome, Milan, and Naples. Leading facilities like Ospedale San Carlo di Nancy and Agostino Gemelli University Policlinic utilize endoscopic sinus surgery (FESS). These centers integrate biological therapies for chronic cases to prevent polyp recurrence.
Bookimed Expert Insight: Patients seeking specialized ENT care in Italy should consider the collaborative nature of major institutions. For example, Mater Olbia Hospital was created through a partnership with the Agostino Gemelli University Policlinic. This allows patients to access university-level expertise in a modern, international setting designed for global healthcare standards.
Patient Consensus: Patients note that choosing private care or specialized university centers is essential to avoid wait times exceeding 6 months. High-volume surgeons in cities like Milan and Rome are preferred for their endoscopic expertise.
Qualifying for Mepolizumab in Italy requires a clinical diagnosis of severe eosinophilic rhinosinusitis with nasal polyps. Patients must demonstrate blood eosinophil levels above 150–300 cells/μL. Documentation must prove standard treatments like corticosteroids or surgery failed to control symptoms before enrollment in the AIFA registry.
Bookimed Expert Insight: Italian clinics like Ospedale Santa Maria are accredited for public health services. This is vital since biologics require AIFA registry clearance. Doctors like Dr. Nicola Vione emphasize specialized ENT expertise in Turin and other major hubs. This focus on surgical and pathological qualifications ensures patients receive the specific eosinophilic coding required for drug approval.
Patient Consensus: Patients note that having asthma alongside polyps often speeds up approval significantly. Many recommend seeing an allergist early because some ENTs may focus only on repeating surgery instead of starting biologics.
Endoscopic sinus surgery is fully covered by the Italian National Health Service (SSN) when medically necessary. Patients must obtain a referral from a general practitioner and an otolaryngology specialist evaluation. Costs are typically borne by the state, though minor co-payments apply for diagnostic tests.
Bookimed Expert Insight: While public coverage is universal, facility type significantly impacts access speed. Clinics like Ospedale San Carlo di Nancy are SSN-accredited and handle 15,000 patients annually. Choosing these accredited centers often provides a middle ground between long public waitlists and high private costs. Specialist Dr. Nicola Vione works within the public system, demonstrating high-level expertise is available under SSN coverage.
Patient Consensus: Patients note that while surgery is free, waiting lists in Rome can reach 8 months. Many recommend pushing for urgent classification from a family doctor to accelerate the surgical timeline.
A typical biologic therapy work-up for nasal polyps in Italy involves extensive diagnostics to confirm severity before the first dose. Travelers undergo ENT endoscopy, CT scans, and specific blood tests like IgE levels and eosinophil counts. Italy ranks 8th globally for medical tourism, offering high-standard private care.
Bookimed Expert Insight: Italian private clinics like Ospedale San Carlo di Nancy handle over 15,000 hospitalizations annually and provide efficient outpatient workflows. While public hospitals may take two days for basic bureaucracy, choosing a specialized private center in Rome or Milan often allows for a same-day loading dose and immediate 1–2 hour monitoring. This significantly reduces necessary hotel nights for international patients during follow-up cycles.
Patient Consensus: Patients emphasize completing bloodwork 4–6 weeks early to avoid travel delays. Many travelers note the importance of a SNOT-22 score above 40 to ensure they meet the clinical criteria for treatment before flying.
Functional Endoscopic Sinus Surgery (FESS) is the standard surgical approach for nasal polyps in Italy. Specialists use endoscopes to remove polyps and clear sinus blockages under general anaesthesia. This technique preserves healthy tissue and improves long-term sinus drainage.
Bookimed Expert Insight: Data from major Italian medical clusters reveals a strong focus on functional outcomes. Ospedale San Carlo di Nancy in Rome manages 14,000 patients annually using modern protocols. Patients should ask their ENT specialist if they hold membership in the SIOeChCF. This helps confirm they follow national multidisciplinary standards.
Patient Consensus: Patients in Italy suggest asking if the plan involves a full clean-out. They also note the importance of confirming a post-operative steroid schedule to prevent recurrence.
Modern biologic therapies like Dupilumab are available in Italy for severe chronic rhinosinusitis with nasal polyps. The Italian Medicines Agency (AIFA) has approved and subsidised this treatment since 2021. Patients access it through authorised centres. Treatment targets adults with uncontrolled cases despite surgery or corticosteroids.
Bookimed Expert Insight: Italy ranks in the top ten countries for medical requests. However, wait times for biologics in the public system can be long. Mater Oblia Hospital in Rome often serves as a faster alternative for international patients. It operates as a global centre through partnerships with international foundations. This makes it a strategic choice for those wanting to bypass public administrative delays.
Patient Consensus: Patients note that biologics effectively reduce the need for repeat revision surgeries. They also reduce constant steroid use. Patients emphasise that private access is faster. However, it requires budgeting for ongoing specialist visits and monitoring.
Australian patients should discuss lifestyle factors and detailed symptom history. They should also list prior medical or surgical treatments for nasal polyps. Specialists in Italy provide endoscopic sinus surgery and medical management. Patients must disclose asthma or aspirin sensitivity for safe treatment. This helps coordinate care between Australian healthcare and Italian specialists.
Bookimed Expert Insight: Italian ENT specialists often work across public university hospitals and private clinics. This provide access to extensive research-based care. For example, Dr Nicola Vione is a Medical Director in a public unit. He also sees patients at private facilities like Santa Caterina da Siena. This dual experience means specialists are well-versed in complex cases and functional nasal surgery.
Patient Consensus: Patients recommend confirming which pathology tests and pre-operative scans the specialist requires. They also suggest asking about long-term medication plans to prevent polyps from returning after surgery.
Italy offers reputable facilities for nasal polyps treatment. They specialise in functional endoscopic sinus surgery and biological therapies. Key centres like Ospedale San Carlo di Nancy in Rome and Ruesch Clinic in Naples provide surgical care. Specialists often hold memberships in the Italian Society of Otolaryngology.
Bookimed Expert Insight: Italian ENT specialists frequently hold dual qualifications in functional and aesthetic nasal surgery. Data shows centres like Mater Olbia Hospital specifically cater to international patients through global partnerships. Choosing a facility with a high volume of complex ENT cases helps ensure access to refined surgical protocols.
Patient Consensus: Patients note it is essential to find surgeons in Italy with specific rhinology experience. They recommend avoiding general practitioners for this treatment. Experience with functional endoscopic sinus surgery and clear post-operative travel timelines are also highly valued.
International patients can access nasal polyp treatments in Italy through private surgical centres and research hospitals. Facilities like Ospedale San Carlo di Nancy in Rome provide Functional Endoscopic Sinus Surgery (FESS) and biologic therapies. Specialist ENT surgeons manage complex cases using minimally invasive techniques.
Bookimed Expert Insight: Italian healthcare data shows a strong focus on high-volume surgical centres. Ospedale San Carlo di Nancy serves about 14,000 patients annually. It belongs to the extensive GVM Care & Research network. High patient volumes often lead to refined surgical protocols for routine ENT procedures.
Patient Consensus: Patients should confirm the clinic manages the whole care pathway from diagnosis to surgery. Many find that requesting medical reports in English helps with follow-up care in Australia.